Building solutions to address drugs shortages in Canada: developing an evidence-based at-risk medicine list

制定解决加拿大药品短缺问题的解决方案：制定基于证据的高危药品清单

• 批准号: 475138
• 负责人: Tadrous Mina
• 金额: $ 10.92万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-10-01 至 2023-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475138&lang=en
• 关键词: Drug Shortages; Formulary; Pharmaceuticals; Supply Chain

One in 4 Canadians report being impacted by a drug shortage in the last two years. We have little knowledge of the true impact of drug shortages among Canadian men and women. This is especially important in the current context of a rising number of drug s

四分之一的加拿大人报告说，在过去两年中受到药物短缺的影响。我们对药物短缺对加拿大男女的真正影响知之甚少。在当前药物数量不断增加的背景下，这一点尤为重要